<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-08-19</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155542/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Age-Related Macular Degeneration and Its Genetic Risk: A Population-based Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155542-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In a population-based setting, we confirmed higher genetic risk to be associated with more severe AMD and identified associations with high-risk features of intermediate AMD. Conjoint analyses suggested that high-risk features and late AMD might be differentially associated with genetic architecture in AMD, such as ECM remodeling. Incorporation of genetic information such as GRSs might improve AMD risk prediction &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155847/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">TEDOVA: vaccine OSE2101 &#43;/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155847-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer is a leading cause of death from gynecological cancers worldwide. Platinum-based chemotherapy provides the cornerstone of the medical management. In first line and subsequent relapses, maintenance strategies are offered to prolong intervals between lines of chemotherapy. Current maintenance options involve bevacizumab and poly ADP-ribose polymerase inhibitors, but these lines of therapy can only be used once in the disease course. Patients in first or second platinum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155851/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">The curious physician: exploring the role of curiosity in professionalism, patient care, and well-being</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155851-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This study represents the first attempt to explore physicians' perspectives on curiosity in medicine. The findings highlight the potential importance of curiosity in shaping medical professionalism and improving patient care. However, its pursuit is hampered by the challenging working conditions faced by doctors, suggesting a need for enhanced support and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156164/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Renal and Extrarenal Phenotypes in Patients With &lt;em&gt;HNF1B&lt;/em&gt; Variants and Chromosome 17q12 Microdeletions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156164-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Patients with the 17q12del display a significantly better kidney survival than patients with other HNF1B variants; and for the latter, variants in the POU(s) DNA-binding domain lead to the poorest kidney survival. These are clinically relevant HNF1B kidney genotype-phenotype correlations that inform genetic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156554/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Prevalence and Associated Factors of Cataract, Cataract Surgery and Postoperative Outcome in an Old Population in Russia: The Ural Very Old Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156554-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Despite a relatively high prevalence of cataract surgery, this multiethnic cohort &gt;85 years of aged from Russia showed a high prevalence of cataract-related MSVI and blindness. Main causes for postoperative MSVI (prevalence: 44.6%) and blindness (prevalence: 11.7%) were AMD, glaucoma, corneal opacifications, and myopic macular degeneration. Almost all individuals aged 85+ years need cataract surgery, despite limited chance of postoperative good &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156943/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Marginal Contribution of Pathogenic &lt;em&gt;RAD51D&lt;/em&gt; Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156943-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: No pathogenic RAD51D variant was identified in the current study. Our study data suggested a negligible association of RAD51D variants with BC/OC risk in Pakistani &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157442/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">A multiparametric analysis including single-cell and subcellular feature assessment reveals differential behavior of spheroid cultures on distinct ultra-low attachment plate types</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157442-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Spheroids have become principal three-dimensional models to study cancer, developmental processes, and drug efficacy. Single-cell analysis techniques have emerged as ideal tools to gauge the complexity of cellular responses in these models. However, the single-cell quantitative assessment based on 3D-microscopic data of the subcellular distribution of fluorescence markers, such as the nuclear/cytoplasm ratio of transcription factors, has largely remained elusive. For spheroid &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157585/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Long non-coding RNAs involved in &lt;em&gt;Drosophila&lt;/em&gt; development and regeneration</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157585-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The discovery of functional long non-coding RNAs (lncRNAs) changed their initial concept as transcriptional noise. LncRNAs have been identified as regulators of multiple biological processes, including chromatin structure, gene expression, splicing, mRNA degradation, and translation. However, functional studies of lncRNAs are hindered by the usual lack of phenotypes upon deletion or inhibition. Here, we used Drosophila imaginal discs as a model system to identify lncRNAs involved in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157610/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157610-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The HOVON 104 studied bortezomib-dexamethasone induction therapy and autologous stem cell transplantation in 50 patients, of whom 35 received an autologous stem cell transplantation (ASCT). We demonstrate a 5-year overall survival (OS) of 73% and progression-free survival (PFS) of 52% for all 50 patients with a median follow-up of 61.3 months. For the 35 transplanted patients, calculated from the date of ASCT, the 5-year OS and PFS were 91% and 68%, respectively. After ASCT, the rate of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158066/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">An unbiased lncRNAs dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158066-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Multiple Myeloma (MM) is an incurable malignancy characterised by altered expression of coding and non-coding genes promoting tumour growth and drug resistance. Although the crucial role of long non-coding RNAs (lncRNAs) in MM is clearly established, the function of the non-coding RNAome, which might allow the design of novel therapeutics, is largely unknown. We performed an unbiased CRISPR-Cas9 loss-of-function screen of 671 lncRNAs in MM cells and their Bortezomib (BZB)-resistant &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158067/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Epigenetic Regulation of Non-canonical Menin Targets Modulates Menin Inhibitor Response in Acute Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158067-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Menin inhibitors that disrupt Menin-MLL interaction hold promise for treating specific acute myeloid leukemia subtypes, including KMT2A rearrangements (KMT2A-r), yet resistance remains a challenge. Here, through systematic chromatin-focused CRISPR screens, along with genetic, epigenetic, and pharmacologic studies in a variety of human and mouse KMT2A-r AML models, we uncover a potential resistance mechanism independent of canonical Menin-MLL targets. We show that a group of non-canonical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158068/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158068-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The genetic background of the high prevalence red blood cell antigen AnWj has remained unresolved since its identification in 1972, despite reported associations with both CD44 and Smyd1 histone methyltransferase. Development of anti-AnWj, which may be clinically significant, is usually due to transient suppression of antigen expression, but a small number of individuals with persistent, autosomally-recessive inherited AnWj-negative phenotype have been reported. Whole exome sequencing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158069/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">How I approach intersectionality in hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158069-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In the context of healthcare, intersectionality refers to a framework that focuses on the ways multiple axes of social inequality intersect and compound at the macro and micro levels to produce a broad range of unequal health outcomes. With the aid of tools such as the wheel of power and privilege, this framework can help identify systemic biases hidden in plain sight in the routine diagnostic, therapeutic, and prognostic paradigms used in clinical practice. Hematopoietic stem &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158071/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158071-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Patients with relapsed/refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) have poor outcomes compared with newly diagnosed, treatment-naïve patients. The phase 2, open-label DELPHINUS study evaluated daratumumab (16 mg/kg intravenously) plus backbone chemotherapy in children with relapsed/refractory B-cell ALL (n=7) after ≥2 relapses and children and young adults with T-cell ALL (children, n=24; young adults, n=5) or LL (n=10) after first relapse. The primary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158072/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158072-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Loss of endothelial barrier function contributes to the pathophysiology of many inflammatory diseases. Coagulation factor XI (FXI) plays a regulatory role in inflammation. While activation of FXI increases vascular permeability in vivo, the mechanism by which FXI or its activated form FXIa disrupts endothelial barrier function is unknown. We investigated the role of FXIa in human umbilical vein endothelial cell (HUVEC) or human aortic endothelial cell (HAEC) permeability. The expression &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158135/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Table Stakes for Equity - Consumer Demographic Data at a State-Based Marketplace</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158135-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158136/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158136-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158139/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Transforming Narratives of Gun Violence</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158139-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158143/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Academic Medical Center-Public Health Partnerships for Outbreak Response - Collaborating with Underresourced Communities</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158143-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Alpha&lt;sub&gt;1&lt;/sub&gt;-Antitrypsin Deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158146/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">An Urban Farm-Anchored Produce Prescription Program - Food as Medicine and Economic Justice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158146-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158147/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">A Multitiered Mentorship Model - Fostering Inclusive Pathways to Health Careers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158147-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158218/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158218-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Autologous hematopoietic cell transplantation (AHCT) is a commonly used treatment in multiple myeloma (MM). However, real-world global demographic and outcome data are scarce. We collected data on baseline characteristics and outcomes from 61 725 patients with newly diagnosed MM who underwent upfront AHCT between 2013 and 2017 from nine national/international registries. The primary endpoint was overall survival (OS), and the secondary endpoints were progression-free survival (PFS), &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158373/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Gold Meets Selenium: Dual Activation of Selenium-Containing Propargyl Alcohols Towards the Synthesis of 2H-Chromenes and Mechanistic Insights</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158373-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Herein, we report the synthesis of seleno-substituted chromenes from selenoalkynes and phenols. In this cascade reaction, the applied gold catalyst not only functions as a p-acid, but also as a Lewis acid, enabling the propargylic substitution in the first step to connect the oxygen carbon bond. Under the optimal reaction condition a total of 26 chromenes were accessible by this modular access. During scale up experiments, the hydrolysis of the vinylselenium substructure to the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158599/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158599-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Results of this study indicate that NOACs may offer a favorable risk-benefit profile for patients with concomitant indication for anticoagulation therapy following &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158601/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Challenging the status quo: A scoping review of value-based care models in cardiology and electrophysiology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158601-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: New VBHC models have the potential to improve the care process and patient experience while optimizing the costs. The implementation of this model has been insufficient mainly because it requires substantial changes in the existing infrastructures and local organization, the need to track adherence to guidelines and the evaluation of the quality of life improvement and patient satisfaction, among &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">The Use of a Comprehensive Concept of Capability for Wellbeing Assessment: A Best-Fit Framework Synthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Developing an instrument with the capability approach can be challenging, since the capability concept of Sen is ambiguous concerning the burdens that people experience whilst achieving their capabilities. A solution is to develop instruments with a comprehensive concept of capability, such as the concept of &lsquo;option-freedom&rsquo;. This study aims to develop a theoretical framework for instrument development with the concept of option-freedom. A best-fit framework synthesis was conducted with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158696/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Chemigenetic Far-Red Labels and Ca&lt;sup&gt;2&#43;&lt;/sup&gt; Indicators Optimized for Photoacoustic Imaging</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158696-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Photoacoustic imaging is an emerging modality with significant promise for biomedical applications such as neuroimaging, owing to its capability to capture large fields of view deep inside complex scattering tissue. However, widespread adoption of this technique has been hindered by a lack of suitable molecular reporters for this modality. In this work, we introduce chemigenetic labels and calcium sensors specifically tailored for photoacoustic imaging, using a combination of synthetic dyes &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158736/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Erratum zu: Kardiale Biomarker vor nicht-kardiochirurgischen Eingriffen</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158736-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158743/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">VEGFD signaling balances stability and activity-dependent structural plasticity of dendrites</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158743-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mature neurons have stable dendritic architecture, which is essential for the nervous system to operate correctly. The ability to undergo structural plasticity, required to support adaptive processes like memory formation, is still present in mature neurons. It is unclear what molecular and cellular processes control this delicate balance between dendritic structural plasticity and stabilization. Failures in the preservation of optimal dendrite structure due to atrophy or maladaptive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158893/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158893-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: These findings show that placing nicardipine release implants during microsurgical aneurysm repair can provide safe and effective prevention of moderate to severe aVS after aSAH. A phase 3 clinical trial to investigate the effect of nicardipine implants on clinical outcome may be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Evaluating and Enhancing the Fitness-for-Purpose of Electronic Health Record Data: Qualitative Study on Current Practices and Pathway to an Automated Approach Within the Medical Informatics for Research and Care in University Medicine Consortium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The study identifies gaps between current practices in MIRACUM DICs and existing recommendations, offering insights into the complexities of assessing and reporting clinical data fitness. Additionally, a tripartite modular framework for fitness-for-purpose assessment was introduced to streamline the forthcoming implementation. It provides valuable input for developing and integrating an automated solution across multiple locations. This may include statistical comparisons &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Ot2SPw2i4">别刀了别刀了[单身狗]//@自闭qwq:当年哪会有人对他说没关系你才20岁呢 - 转发 @炸九:&amp;ensp;补了04雅典决赛，从比赛结束之后到颁奖完回后台的接近半个小时里，王...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-ot2spw2i4/">
    
    
    
    
    
      
    
    别刀了别刀了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@自闭qwq<!-- raw HTML omitted -->:当年哪会有人对他说没关系你才20岁呢<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@炸九<!-- raw HTML omitted -->: 补了04雅典决赛，从比赛结束之后到颁奖完回后台的接近半个小时里，王乐好像连眼睛都不会眨了😢<!-- raw HTML omitted -->赛后央视采访，记者连线报幕期间一直维持P1的姿势JPG一动不动了快二十秒，不知道在想些什么。中间被撞到背包水洒出来整个人失魂落魄到顶点，最后告别记者安慰他“王皓没关系”也一直垂着头懵懵的<!-- raw HTML omitted -->颁奖的时候，握手微笑 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV16y411i7yD">【张捷财经】金价再创新高与全球猛料加持</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv16y411i7yd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1AW421R7ia">【张捷聊三农之百七八】进一步提高城镇化，三农问题要发展中解决</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1aw421r7ia/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1eS42197Ro">【张捷聊科技】腾讯的苹果税安卓税与消费者权益之差别</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1es42197ro/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155339/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155339-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: MDT is a very effective treatment modality for prostate cancer bone oligometastases and lesion response to MDT can be assessed using the (semi-)quantitative parameters SUV(max) and PSMA-positive lesion volume with established SUV &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OsNs8uzwF">Mulibu Farm Tiburon，在patio上可以看到SF。在这里让人觉得放松。 美国·Tiburon Ferry Terminal 子陵在听歌的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-osns8uzwf/">
    
    
    
    
    
      
    
    Mulibu Farm Tiburon，在patio上可以看到SF。在这里让人觉得放松。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·Tiburon Ferry Terminal<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.pn">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.pn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OsOLBloxQ">上周六NYT/Siena公布了Biden退选后最重要rust belt（锈代）三大摆动州PA/MI/WI民调结果（网页链接），Harris均领先4%。今天NYT/Siena又公布了sun belt四州AZ/NC/...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-osolbloxq/">
    
    
    
    
    
      
    
    上周六NYT/Siena公布了Biden退选后最重要rust belt（锈代）三大摆动州PA/MI/WI民调结果（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->），Harris均领先4%。今天NYT/Siena又公布了sun belt四州AZ/NC/NV/GA的民调结果，Harris在AZ领先5%，在非摆动州NC领先2%；在NV落后1%，在GA落后5%。这个民调显示本来Biden这四个少数族裔（非裔和拉丁裔）占大比重的州均落后；但 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OsPt6na8y">我的心理医生（therapist）在每次心理咨询（session）后都会给我发一个教学动画。我这周收到的两个教学视频是价值（value）和信念（mindfulness）。把两个视频的...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ospt6na8y/">
    
    
    
    
    
      
    
    我的心理医生（therapist）在每次心理咨询（session）后都会给我发一个教学动画。我这周收到的两个教学视频是价值（value）和信念（mindfulness）。把两个视频的要义简单总结一下就是两点：不要与别人比较；不要因为他人制定的标准而焦虑。<!-- raw HTML omitted --><!-- raw HTML omitted -->不要与人比其实说起来简单，但做起来很难。很多人小时候经常被家长或老师拿来与别的孩子比较；同样是小时候，当别人有双崭新的耐克球鞋时，我们自己也会想去拥有一双，出发点是为了寻找心理平衡。成年后，这种比较更是无处不在，典型的如房子、车、工资、子女教育等等。这种比较已经成为了很多人的思维定势。<!-- raw HTML omitted --><!-- raw HTML omitted -->有趣的是，我在国内时认识不少清华本科生，我觉得他们已经是万里挑一的的天之 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTPc7xPr">🔻另外，今天有很多账号一直在刷“没有过中线”、“承认中线”。🔻通过公开的AIS信息查询了一下巡航轨迹如图，在海峡内巡航都在所谓的“中线”东侧（靠台湾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostpc7xpr/">
    
    
    
    
    
      
    
    🔻另外，今天有很多账号一直在刷“没有过中线”、“承认中线”。<!-- raw HTML omitted -->🔻通过公开的AIS信息查询了一下巡航轨迹如图，在海峡内巡航都在所谓的“中线”东侧（靠台湾岛一侧），距离所谓“中线”最近距离约2海里，最远达到了约22海里。<!-- raw HTML omitted -->🔻这就相当于执法巡航时压根不承认所谓“中线”存在了。<!-- raw HTML omitted -->🔻警惕有些浑水摸鱼、混淆视听的。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTTR70Jj">🔻为毛我的预载卡住了？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osttr70jj/">
    
    
    
    
    
      
    
    🔻为毛我的预载卡住了？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTU4aqta">巡航路线是根据航行速度着色的。//@玉兰锈帕:回复@丸子北极熊:感谢赐教[作揖]。那根浅蓝线怎么有一小段呈现绿色，这应该没什么别的意思表达吧？ //@玉兰锈帕:没...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostu4aqta/">
    
    
    
    
    
      
    
    巡航路线是根据航行速度着色的。//<!-- raw HTML omitted -->@玉兰锈帕<!-- raw HTML omitted -->:回复<!-- raw HTML omitted -->@丸子北极熊<!-- raw HTML omitted -->:感谢赐教<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->。那根浅蓝线怎么有一小段呈现绿色，这应该没什么别的意思表达吧？ //&lt;a href=&ldquo;<a href="https://weibo.com/n/%E7%8E%89%E5%85%B0%E9%94%88%E5%B8%25">https://weibo.com/n/%E7%8E%89%E5%85%B0%E9%94%88%E5%B8%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTWr9KdR">🔻你猜？🔻无论如何，讨论一个“不存在”的东西并没有什么意义，但是我们这边的许多网友却又要一遍又一遍的拿出来问，不得不一遍又一遍的解释。🔻对有些人...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostwr9kdr/">
    
    
    
    
    
      
    
    🔻你猜？<!-- raw HTML omitted -->🔻无论如何，讨论一个“不存在”的东西并没有什么意义，但是我们这边的许多网友却又要一遍又一遍的拿出来问，不得不一遍又一遍的解释。<!-- raw HTML omitted -->🔻对有些人来说，破“海峡中线”易，破“心中中线”难。<!-- raw HTML omitted -->🔻AIS数据来自VF <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTZLpWXv">🔻老纠结“渔船过没过海峡中线”其实很无聊，随便点几条作业中的中国渔船，看看他们在哪。🔻AIS数据来自VF [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostzlpwxv/">
    
    
    
    
    
      
    
    🔻老纠结“渔船过没过海峡中线”其实很无聊，随便点几条作业中的中国渔船，看看他们在哪。<!-- raw HTML omitted -->🔻AIS数据来自VF <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsU4m8tfB">🔻这些在身体控制、时间掌握和激烈对抗中做到顶级的一流运动员，只要性格没缺陷，无论人生道路如何继续，都是超越常人的存在。🔻有些人自己的职业生涯、本职...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osu4m8tfb/">
    
    
    
    
    
      
    
    🔻这些在身体控制、时间掌握和激烈对抗中做到顶级的一流运动员，只要性格没缺陷，无论人生道路如何继续，都是超越常人的存在。<!-- raw HTML omitted -->🔻有些人自己的职业生涯、本职工作做的都很平庸，却大言不惭“让我来批评批评你”<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#全红婵跳207C经常平摔进水里#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hssimleqltj21em0r1e2l.jpg%22">https://tvax2.sinaimg.cn/large/639b1bfbly1hssimleqltj21em0r1e2l.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUaa5gxT">“恶性”两字没变，吃台🐸洗脑包还到处捧着给人看是很搞笑的。 查看图片 //@岚风山:过中线如何，不过中线又如何？214恶意撞船事件变成214撞船事件后国人一切试...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osuaa5gxt/">
    
    
    
    
    
      
    
    “恶性”两字没变，吃台🐸洗脑包还到处捧着给人看是很搞笑的。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --> //<!-- raw HTML omitted -->@岚风山<!-- raw HTML omitted -->:过中线如何，不过中线又如何？214恶意撞船事件变成214撞船事件后国人一切试图在海上找补的做法都很可笑<!-- raw HTML omitted -->&lt;img alt=&quot;[挖鼻]&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUeMFwJ0">🔻冠军，好难。#樊振东回应退役传闻# [图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osuemfwj0/">
    
    
    
    
    
      
    
    🔻冠军，好难。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#樊振东回应退役传闻#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUgn1jQ9">就正常几十帧的配置//@叶Vinde:想问问包姐电脑啥配置 - 转发 @包容万物恒河水:&amp;ensp;🔻为毛我的预载卡住了？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osugn1jq9/">
    
    
    
    
    
      
    
    就正常几十帧的配置//<!-- raw HTML omitted -->@叶Vinde<!-- raw HTML omitted -->:想问问包姐电脑啥配置<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻为毛我的预载卡住了？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUQntRVb">🔻刚刚。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osuqntrvb/">
    
    
    
    
    
      
    
    🔻刚刚。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OsO1Mm00P">早餐新品种：鹌鹑蛋。喵奶奶说听说鹌鹑蛋的蛋白质含量是鸡蛋的3倍，我问听谁说？她说网上说的。我说肯定是鹌鹑自己在网上说的，她说管他谁说的，反正我想吃鹌鹑...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oso1mm00p/">
    
    
    
    
    
      
    
    早餐新品种：鹌鹑蛋。喵奶奶说听说鹌鹑蛋的蛋白质含量是鸡蛋的3倍，我问听谁说？她说网上说的。我说肯定是鹌鹑自己在网上说的，她说管他谁说的，反正我想吃鹌鹑蛋。马上在盒马下单，买了一盒0抗生素的鹌鹑蛋。不说蛋白质含量，口感确实比鸡蛋好3倍。<!-- raw HTML omitted --> 我得介绍一下蔬菜色拉，作料三：食盐、黑胡椒粉和橄榄油。重点是胡椒粉。这个胡椒粉是我们在土耳其超市买的，回国时我说扔了，被喵奶奶悄悄带回来。比较成都超市的胡椒粉，差别真的很大。如果我说土耳其胡椒粉比中国胡椒粉香，不会被认为是崇洋媚外吧？现在有点后悔，应该多买两袋。我在京东、盒马搜索，都没有土耳其胡椒粉。喵奶奶说看看最近有没有朋友到土耳其旅游，让帮忙买两袋？我说除非人家自由行，如果跟团游，咋可能去逛生活超市？ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OsPx0APOg">书上说，每周应该吃两次鱼和豆腐。喵奶奶就在盒马鲜生下单，买了一盒鲈鱼片和豆腐，要我做豆腐鱼。我说这种鱼片是拿来烫火锅的，她说未必烫火锅的就不能做成豆腐...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ospx0apog/">
    
    
    
    
    
      
    
    书上说，每周应该吃两次鱼和豆腐。喵奶奶就在盒马鲜生下单，买了一盒鲈鱼片和豆腐，要我做豆腐鱼。我说这种鱼片是拿来烫火锅的，她说未必烫火锅的就不能做成豆腐鱼？我说你懂个屁，只晓得吃吃吃！须知做豆腐鱼的鱼必须切成块，而不是切片。她说那就把鱼片做成酸菜鱼，豆腐做成麻婆豆腐？我说你说得轻巧，吃根灯草——花椒粉都没有，咋个做麻婆豆腐呢？她说花椒粉多简单嘛，抓一把花椒在锅里炒香，冷却后，用舂钵把花椒舂成粉，不就是花椒粉？花椒粉很快就制造出来了，麻婆豆腐顺利诞生，我说比何氏骨科医院食堂的麻婆豆腐好吃吧？喵奶奶说逗是。鱼没有做成酸菜鱼——我认为用超市卖的酸菜鱼调料包来烹鱼，等于预制菜，没有创造性。我是用鲜花椒和姜葱蒜，把鲈鱼片做成了可能只有四川人重庆人才敢吃的椒麻鱼。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sin">https://tvax3.sin</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsPBLzlg2">夺少？ - 转发 @Aniplex:&amp;ensp;【ANIPLEX转现通知】乃木坂46 集换式卡牌卡垫已经现货上架啦！收纳盒售价：70元卡垫(3期生/4期生/5期生)售价：各190元 店铺：🍑...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ospblzlg2/">
    
    
    
    
    
      
    
    夺少？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@Aniplex<!-- raw HTML omitted -->: 【ANIPLEX转现通知】<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->乃木坂46<!-- raw HTML omitted --><!-- raw HTML omitted --> 集换式卡牌卡垫已经现货上架啦！<!-- raw HTML omitted -->收纳盒售价：70元<!-- raw HTML omitted -->卡垫(3期生/4期生/5期生)售价：各190元 <!-- raw HTML omitted -->店铺：🍑aniplex旗舰店 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsPj09Y6J">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.緒行記fb [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ospj09y6j/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.緒行記fb &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hsrvjosprij30u00k0mzp.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hsrvjosprij30u00k0mzp.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsQx03Sla">//@顶筆TEN使:久保史绪里[耶][亲亲] - 转发 @長亭梅:&amp;ensp;梅泽美波#梅泽美波# 2024.08.12 手机mail「梅绪」&lt;图&gt;是梅绪哦☺️☺️MV一直在一起 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-osqx03sla/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[耶]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/h_ye-8d6db3a711.png%22">https://h5.sinaimg.cn/m/emoticon/icon/others/h_ye-8d6db3a711.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsRlO1JCP">好想见重庆女人 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-osrlo1jcp/">
    
    
    
    
    
      
    
    好想见重庆女人 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsVj3jCuV">每天晚上都有不睡觉的理由昨晚是和蚊子大战到五点今天是陪伴到三点又打游戏到四点多唉这日子过得，今晚一定早睡🚬</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-osvj3jcuv/">
    
    
    
    
    
      
    
    每天晚上都有不睡觉的理由<!-- raw HTML omitted -->昨晚是和蚊子大战到五点<!-- raw HTML omitted -->今天是陪伴到三点又打游戏到四点多<!-- raw HTML omitted -->唉这日子过得，今晚一定早睡🚬  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OsRBt22yQ">不愧是我们山西队名宿棋手战鹰 - 转发 @棋手战鹰:&amp;ensp;和好朋友们一起聚餐狂吃狂吃的两天，仿佛回到了两年前下围甲的时候，好放松～[比耶]嘿嘿嘿，我爱山西队！...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-osrbt22yq/">
    
    
    
    
    
      
    
    不愧是我们山西队名宿<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@棋手战鹰<!-- raw HTML omitted -->: 和好朋友们一起聚餐狂吃狂吃的两天，仿佛回到了两年前下围甲的时候，好放松～<!-- raw HTML omitted -->&lt;img alt=&quot;[比耶]&quot; src=&ldquo;<a href="https://face.t.sinaj">https://face.t.sinaj</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OsTwKlZpQ">发布了头条文章：《一力辽下出“足以载入历史的妙手”，距离世界冠军还需一胜》 #围棋# 围棋 一力辽下出“足以载入历史的妙手”，距离世界冠军还需一胜 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ostwklzpq/">
    
    
    
    
    
      
    
    发布了头条文章：《一力辽下出“足以载入历史的妙手”，距离世界冠军还需一胜》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted -->&lt;/ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OsU90gTQx">棋手战鹰我不太懂，西游记要翻拍了？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-osu90gtqx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted -->我不太懂，西游记要翻拍了？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OsOOilTMz">久保史绪里via.緒行記fb [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-osooiltmz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.緒行記fb <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OsQ30eb2D">久保史绪里[耶][亲亲] - 转发 @長亭梅:&amp;ensp;梅泽美波#梅泽美波# 2024.08.12 手机mail「梅绪」&lt;图&gt;是梅绪哦☺️☺️MV一直在一起 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-osq30eb2d/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OsQAIf5Lr">柯洁#野狐人气争霸赛##赛果发布# 潜伏执白 164手胜 我想静静了（党毅飞九段）。恭喜柯柯先下一城～[鼓掌][鼓掌][鼓掌] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-osqaif5lr/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV15E421w7zv">下次找工作，就带我妈去！</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv15e421w7zv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1i2421Z7fH">【张捷杂谈】网络勒索精准诈骗，应该按照抢劫定性</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1i2421z7fh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1qE421w7DP">【张捷说法】深度反腐，严查干部兼职利益输送</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1qe421w7dp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Tw4m1k7pi">【张捷财经】借贷欺诈的普遍性与刑法缺位</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1tw4m1k7pi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1V1421t7NF">这就是中国·预告：美国军事霸权正迅速丧失｜汪涛</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1v1421t7nf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1yi42167wx">陈翔六点半：那些年我们背过的锅...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1yi42167wx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

